BCL2-Interacting Killer (Apoptosis-Inducing) (BIK) (N-Term) Peptide
BIK
Reactivity: Human
BP
Sodium azide
-
- Target See all BIK products
- BIK (BCL2-Interacting Killer (Apoptosis-Inducing) (BIK))
- Protein Region
- N-Term
- Origin
- Human
- Application
- Blocking Peptide (BP)
- Characteristics
-
15 amino acids near the amino terminus of human Bik.
Human
-
-
- Application Notes
- Bik peptide is used for blocking the activity of Bik.
- Restrictions
- For Research Use only
-
- Format
- Liquid
- Concentration
- 200 μg/mL
- Buffer
- PBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1 % bovine serum albumin and 0.02 % sodium azide
- Preservative
- Sodium azide
- Precaution of Use
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Storage
- -20 °C
- Expiry Date
- 12 months
-
- Target
- BIK (BCL2-Interacting Killer (Apoptosis-Inducing) (BIK))
- Synonyms
- BIK Peptide, Biklk Peptide, Blk Peptide, Nbk Peptide, BIP1 Peptide, BP4 Peptide, NBK Peptide, si:dkey-31f5.6 Peptide, BCL2 interacting killer Peptide, BCL2-interacting killer Peptide, BCL2-interacting killer (apoptosis-inducing) Peptide, BIK Peptide, Bik Peptide, bik Peptide
-
You are here:
